Summary

Description

The datasets contain recorded crime figures for police force areas. The data are rolling 12 month totals, with data points shown at the end of each financial year between 2002/03 and 2006/07 and at the end of each quarter from June 2007. The data tables below contain police recorded crime (PRC) figures broken down by Community Safety Partnership, quarterly period and individual offence code. It is recommended that users consult the User Guide to Crime Statistics in conjunction with these tables for background information on the context and limitations of PRC data. The User Guide to Crime Statistics is a reference guide with explanatory notes regarding the issues and classifications which are key to the production and presentation of crime statistics, including commentary about appropriate interpretation of theses statistics. From 1 April 2012, National Statistics on crime previously published by the Home Office will be published by the Office for National Statistics (ONS).

Summary

Description

Payments to suppliers over £500 from April 2010 to September 2012 Payments to suppliers over £250 October 2012 onwards.

Summary

Description

In 2009 G8 Leaders made a public commitment to monitor their progress on the promises they have made on development. Since the Muskoka G8 summit in 2010 they have published an annual Accountability Report. This year’s report has been published ahead of the Lough Erne Summit, as a concrete demonstration of transparency and accountability that will be key themes of the Summit. The report covers over 60 development commitments made over the past 11 years covering nine key development challenges: Aid and Aid Effectiveness, Economic Development, Health, Water and Sanitation, Food Security, Education, Governance, Peace and Security, and Environment and Energy. These have been self-assessed using an innovative scorecard approach using a 5 point Red-Amber-Green rating in an effort to make the report more accessible and to track progress against the promises in a more transparent way. The assessments use a combination of publically available, independently verifiable data and G8 members self-assessments for some of the more qualitative commitments. The Lough Erne Accountability report reflects the G8’s own assessment of its progress on development promises. In the spirit of mutual accountability and to foster continuing improvement we asked a number of key stakeholder organisations to comment on the report. We are grateful to the UN Economic Commission for Africa and the Overseas Development Institute for taking time to review the report. Their views are available here. We welcome these and hope they will help stimulate further debate about G8 accountability. We undertake to take these views into consideration and feed them into the G8 accountability process under future Presidencies. These are csv files of the data behind the tables included in the report.

Summary

Description

This dataset is held on the Local Directgov platform which provides the deep links into Local council websites for a number of services in Directgov. The Local Authority Service details holds the local council URLS for over 240 services where the customer can directly transfer to the appropriate service page on any council in England.

Summary

Description

Details of meetings with external organisations (inclusing meetings with newspaper and other media proprietors, editors and senior executives)

Summary

Description

This release covers offences involving metal theft recorded by police in England and Wales. Metal theft is not a crime defined by law, but is recorded by police under broader offence classifications, such as other theft offences and burglary. It refers to thefts of items for the value of their constituent metals, rather than the acquisition of the item. This release, where possible, differentiates between infrastructure-related metal theft and non-infrastructure-related metal theft.

Summary

Description

The information available from comes from the Myocardial Ischaemia National Audit Project (MINAP). The audit covers all hospital in England that admit acute coronary syndrome patients. The data were first published in the MINAP 2011 Public report. What information is being made available? Use of reperfusion treatment by hospital, ambulance service and cardiac network. Use of secondary prevention medication on discharge by hospital. These data do not contain data about individual patients nor do they contain any patient identifiable data.

Summary

Description

This audit covers all NHS and some private hospitals in the UK with an adult cardiac surgery service. However the data here only includes English NHS data. English NHS hospital level data from the National Adult Cardiac Surgery Audit covering April 2008 – March 2011. This includes analysis of the number of patient who die after the most common types of heart operations. Also provided are data on the urgency of operations to bypass blockages in the arteries (CABG) and the completeness of the data submitted by hospitals for analysis. The data files included are: • Activity & crude mortality for emergency & salvage operations • Isolated first-time CABG by operative urgency • Activity & risk adjusted mortality isolated first time CABG • Activity & risk adjusted mortality isolated first-time AVR • Risk Factor data completeness

Summary

Description

Please find details of The National Archive's energy consumption at their main building in Kew.

Summary

Description

Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. Each year data from the National Bowel Cancer Audit will be made available in CSV format. The data are also being made available on the data.gov website. What information is being made available? Audit participation by NHS Trust and data completeness for the key fields. Measures about the process of care given to patients. Information about care outcomes and treatment. Trusts and Networks are identified by name and their national code. These data do not list individual patient information, nor do they contain any patient identifiable data. The National Bowel Cancer Audit Project is a high profile, collaborative, national clinical audit for bowel cancer run jointly by The Health and Social Care Information Centre and the Association of Coloproctology of Great Britain and Ireland (ACPGBI). The NHS Information Centre's National Clinical Audit Support Programme (NCASP) provides project management and the technical infrastructure, while the ACPGBI provides clinical leadership and direction. National Bowel Cancer Audit Consultation Document (pdf 92KB). The audit aims to improve the quality of care and survival of patients with bowel cancer. It meets the requirements as set out in the NHS Cancer Plan, NICE guidelines and the Report of the Bristol Royal Infirmary Inquiry. The National Bowel Cancer Audit 2009/10 covers the time period from 1st August 2009 to 31st July 2010 and only Hospital sites within England are included.

Summary

Description

Making clinical audit data transparent. In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. Each year data from the National Bowel Cancer Audit will be made available in CSV format. The data are also being made available on the data.gov website. What information is being made available? Audit participation by NHS Trust and data completeness for the key fields. Measures about the process of care given to patients. Information about care outcomes and treatment. Trusts and Networks are identified by name and their national code. These data do not list individual patient information, nor do they contain any patient identifiable data. The National Bowel Cancer Audit Project is a high profile, collaborative, national clinical audit for bowel cancer run jointly by The Health and Social Care Information Centre and the Association of Coloproctology of Great Britain and Ireland (ACPGBI). The NHS Information Centre's National Clinical Audit Support Programme (NCASP) provides project management and the technical infrastructure, while the ACPGBI provides clinical leadership and direction. The audit aims to improve the quality of care and survival of patients with bowel cancer. It meets the requirements as set out in the NHS Cancer Plan, NICE guidelines and the Report of the Bristol Royal Infirmary Inquiry. The National Bowel Cancer Audit 2011-2012 covers the time period from 1st April 2011 to 31st March 2012. Hospital sites within England are included.

Summary

Description

Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. Each year data from the National Bowel Cancer Audit will be made available in CSV format. The data are also being made available on the data.gov website. What information is being made available? Audit participation by NHS Trust and data completeness for the key fields. Measures about the process of care given to patients. Information about care outcomes and treatment. Trusts and Networks are identified by name and their national code. These data do not list individual patient information, nor do they contain any patient identifiable data. The National Bowel Cancer Audit Project is a high profile, collaborative, national clinical audit for bowel cancer run jointly by The Health and Social Care Information Centre and the Association of Coloproctology of Great Britain and Ireland (ACPGBI). The NHS Information Centre's National Clinical Audit Support Programme (NCASP) provides project management and the technical infrastructure, while the ACPGBI provides clinical leadership and direction. The audit aims to improve the quality of care and survival of patients with bowel cancer. It meets the requirements as set out in the NHS Cancer Plan, NICE guidelines and the Report of the Bristol Royal Infirmary Inquiry. The National Bowel Cancer Audit 2010-2011 covers the time period from 1st August 2010 to 31st July 2011, Hospital sites within England are included.

Summary

Description

Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. Each year data from the National Diabetes Audit will be made available in CSV format. The data are also being made available on the data.gov website. What information is being made available? Audit participation by Primary Care Trusts (PCTs) Measures about the process of care given to patients. Information about care outcomes and treatment. Information about complications and mortality PCTs are identified by name and their national code. These data do not list individual patient information, nor do they contain any patient identifiable data. The National Diabetes Audit is a high profile, collaborative, national clinical audit for diabetes. The National Diabetes Audit was run by the NHS Information Centre with Diabetes UK and Yorkshire and Humber Public Heath Observatory, commissioned by HQIP. The audit aims to improve the quality of care in people with diabetes. It meets the requirements as set out in the NICE guidelines. The National Diabetes Audit 2010/11 covers the time period from 1 January 2010 up to 31 March 2011 with information from GP Practices and specialist diabetes units in England.

Summary

Description

Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. Each year data from the National Diabetes Inpatient Audit will be made available in CSV format. The data are also being made available on the data.gov website. What information is being made available? Audit participation by NHS Trust and data completeness for the key fields. Measures about the process of care given to patients. Information about care outcomes and treatment. Trusts and Networks are identified by name and their national code. These data do not list individual patient information, nor do they contain any patient identifiable data. The National Diabetes Inpatient Audit (NaDIA) is commissioned by the Healthcare Quality Improvement Partnership (HQIP) and delivered by the Health and Social Care Information Centre, working with Diabetes UK. The National Diabetes Inpatient Audit is a snapshot audit of diabetes inpatient care in England. The audit is set out to answer the following questions: Did diabetes management minimise the risk of avoidable complications? Did harm result from the inpatient stay? Was patient experience of the inpatient stay favourable? Has the quality of care and patient feedback changed since NaDIA 2010? The audit takes place every year in autumn. NaDIA 2011 was carried out by diabetes teams in acute hospitals in England on a nominated day in the first two weeks of October

Summary

Description

Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. Each year data from the Head and Neck Cancer Audit will be made available in CSV format. The data are also being made available on the data.gov website. What information is being made available? Audit participation by NHS Trust and data completeness for the key fields. Measures about the process of care given to patients. Information about care outcomes and treatment. Trusts and Networks are identified by name and their national code. These data do not list individual patient information, nor do they contain any patient identifiable data. The National Head and Neck Cancer Audit focuses on cancer sites within the head and neck (excluding tumours of the brain and thyroid cancers). The most common of which being the larynx and in the oral cavity. The Head and Neck Cancer Audit Project is a high profile, collaborative, national clinical audit for bowel cancer run by The Health and Social Care Information Centre and developed in partnership with the British Association of Head and Neck Oncologists (BAHNO) The audit aims to improve the quality of care and survival of patients with Head and Neck cancer. It meets the requirements as set out in the NHS Cancer Plan and NICE guidelines. The Head and Neck Cancer Audit 2011 covers the time period from 1st November 2010 to 31st October 2011 and only Hospital sites within England are included in these csv files.

Summary

Description

Making clinical audit data transparent. In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. Each year data from the National Head and Neck Cancer Audit will be made available in CSV format. The data are also being made available on the data.gov website. What information is being made available? Audit participation by NHS Trust and data completeness for the key fields. Measures of aspects of the care given to patients. Information about care outcomes and treatment. Trusts and Networks are identified by name and their national code. These data do not list individual patient information, nor do they contain any patient identifiable data. The National Head and Neck Cancer Audit focuses on cancer sites within the head and neck (excluding tumours of the brain and thyroid cancers). The most common of which are the larynx, oropharynx and in the oral cavity. The National Head and Neck Cancer Audit is commissioned and sponsored by the Healthcare Quality Improvement Partnership (HQIP) and developed in partnership with the British Association of Head and Neck Oncologists (BAHNO). The Health and Social Care Information Centre provides project management and technical infrastructure. The National Head and Neck Cancer Audit 2012, Eighth Annual Report provided information that represents 7726 cases of head and neck cancer from England and 546 cases from Wales. The report, therefore, represents a comprehensive overview of head and neck cancer care, and this supporting dataset contains those England indicators in the report. The National Head and Neck Cancer Audit 2011-2012 covers the time period from 1st November 2011 to 31st October 2012. Trusts and networks within England are included.

Summary

Description

The outcome of hip fracture serves as a key marker of the quality of hospital care across the many disciplines and departments who collaborate before, during and after this operation. However, the immediate physiological stress experienced by these patients is the pain and blood loss associated with the fracture. High quality anaesthetic care is crucial to the effective management of both stresses. Clinicians interested in promoting better anaesthetic management of patients with hip fracture came together in 2007. The Hip Fracture Perioperative Network (HipPeN) grew from this, and produced a report in 2010 highlighting wide variations in anaesthetic practice. HipPeN has since completed several projects – leading to publication of the Association of Anaesthetists of Great Britain and Ireland (AAGB&I) guidelines on the anaesthetic management of hip fracture in 2012. The National Hip Fracture Database (NHFD) is the largest hip fracture database in the world. The database includes surgical and mortality data on a third of a million patients. It captures 95% of all new cases of hip fracture, with data from all hospitals in England, Wales, Northern Ireland and the Channel Islands, and provides an ideal infrastructure for large audits. Public funding was provided through the Healthcare Quality Improvement Partnership (HQIP); the NHFD has now been incorporated into the Falls and Fragility Fracture Audit Programme (FFFAP) administered by the Royal College of Physicians (RCP). Collaboration between the AAGB&I and the NHFD culminated in this 2014 report which profiles approaches to peri-operative care across England, Wales and Northern Ireland. ASAP set out to collect data on everyone over the age of 60 who had hip fracture surgery in hospitals across England, Wales and Northern Ireland between 1st May and 31st July 2013. The aim of ASAP was to profile individual hospitals’ compliance with the standards for peri-operative care defined by the National Institute of Health and Care Excellence (NICE) in 2011, and the Association of Anaesthetists of Great Britain and Ireland (AAGB&I) in 2012. The audit covers England, Wales, Northern Ireland, the Isle of Man and the Channel Islands, however data files only refer to data for England.

Summary

Description

This dataset shows individual trust- and unit-level activity and outcomes for hip and knee replacement surgery in 2012 for the NHS and private sector. It has been reproduced from the full NJR 10th Annual Report 2013 and covers the specific period January to December 2012. The data published on this page only applies to England. The National Joint Registry of England, Wales and Northern Ireland (NI) publishes data from all territories, where achievable, as part of annual reporting process. The full NJR 10th Annual Report includes 2012 results for Welsh Health Boards (NI joined in Feb 2013). The data shows information relating to how individual trusts and hospitals in England have performed against a range of key measures including whether they have been identified as an ‘outlier’ for mortality and revision rates. Key measures: Hospitals have been awarded a green (≥95%), amber (≥80%) or red (>80%) rating to reflect how well they performed in 2011 based on consent, compliance and linkability. Compliance information is published at trust-level. All other information is published by individual hospital in the NHS and private sector. Outlier analysis: Outlier analysis aims to identify ‘unusual differences’ in data from ‘normal variations’ which may indicate the need for further investigation. For mortality and revision rates, an outlier will be a hospital with an unusually high proportion – more than would normally be expected. Outliers are identified by a 'Y.' The NJR has also listed the following information for each hospital: • Number of consultants • Average ASA grade • Percentage of male patients • Average age at operation • Percentage of 10A rated acetabular hip and femoral hip implants

Summary

Description

This dataset shows individual trust- and unit-level activity and outcomes for hip and knee replacement surgery in 2011 for the NHS and private sector. It has been reproduced from the full NJR 9th Annual Report 2012 and covers the specific period January to December 2011. The data published on this page only applies to England. The National Joint Registry of England, Wales and Northern Ireland (NI) publishes data from all territories, where achievable, as part of annual reporting process. The full NJR 9th Annual Report includes 2011 results for Welsh Health Boards (NI joined in 2013). The data shows information relating to how individual trusts and hospitals in England have performed against a range of key measures including whether they have been identified as an ‘outlier’ for revision rates. Key measures: Hospitals have been awarded a green (≥95%), amber (≥80%) or red (>80%) rating to reflect how well they performed in 2011 based on consent, compliance and linkability. Compliance information is published at trust-level. All other information is published by individual hospital in the NHS and private sector. Outlier analysis: Outlier analysis aims to identify ‘unusual differences’ in data from ‘normal variations’ which may indicate the need for further investigation. For revision rates, an outlier will be a hospital with an unusually high proportion of revision rates – more than would normally be expected. Outliers are identified by a 'Y.' The NJR has also listed the following information for each hospital: • Number of consultants • Average ASA grade • Percentage of male patients • Average age at operation • Percentage of 10A rated acetabular hip and femoral hip implants

Summary

Description

Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister restated the commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. The National Lung Cancer Audit (NLCA) was identified as the pilot for this data release. The data was released in an open and standardised format for the first time in December 2011, and each year onward, data from the National Lung Cancer Audit will be made available in CSV format. The data are also being made available on the data.gov website. Covering all Cancer Networks and NHS Trusts in England, the data from the audit includes information about data completeness, audit process and outcome measures. The data will be available in a pdf format with the National Lung Cancer Audit 2012 annual report. What information is being made available? Measures about the process of care given to patients Information about care outcomes and treatment. The data also provides Audit participation by Trust and data completeness for the key fields. This data does not list data about individual patients nor does it contain any patient identifiable data. Using and interpreting the data Data from the National Lung Cancer Audit requires careful interpretation, and the information should not be looked at in isolation when assessing standards of care. Data is analysed either by cancer network or by place first seen in secondary care for the calendar year 2012. As a result, some trusts that only provide some specialist treatments for patients and do not routinely supply diagnostic data are not properly represented in these data. This is because all the analyses of the NLCA to date have been carried out by 'place first seen' and cancer networks. The ‘place first seen' most closely represents the Clinical Multi-Disciplinary Team (MDT) which makes the first treatment decisions (in partnership with representatives from the specialist centres who sit on these peripheral MDTs). We largely know the population base for these MDTs and that number provides the ‘denominator' for the outcome measures. It is much more difficult to define a population denominator for specialist centres and the treatment they provide is usually only one part of a complex care pathway. So taking the raw data at face value gives a very distorted picture both of their activity and performance. Accessing the data The data are being made available on the data.gov website. Each year two files of data from the National Lung Cancer Audit will be made available in CSV format. Trusts and Networks are identified by name and their national code. What does the data cover? The data measure levels of completeness for data submitted to the NLCA and measures of performance in the audit at trust level for key performance measures for assessing standards of care for lung cancer in secondary care. Details of these standards can be found in appendix 2 of the NLCA report. Are all Trusts included? All Trusts in England that manage patients diagnosed with lung cancer (excluding mesothelioma) are included. The audit also covers Wales. What period does the data cover? This data were extracted from the NLCA database in July 2013 and covers patients first seen in the calendar year 2012.

Summary

Description

Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister restated the commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. The National Lung Cancer Audit (NLCA) was identified as the pilot for this data release. The data was released in an open and standardised format for the first time in December 2011, the data has been provided annually from then onwards. Covering all Cancer Networks and NHS Trusts in England, the data from the audit includes information about data completeness, audit process and outcome measures. The data will be available in a pdf format in the National Lung Cancer Audit 2011 annual report. What information is being made available? Measures about the process of care given to patients Information about care outcomes and treatment. The data also provides Audit participation by Trust and data completeness for the key fields; These data do not list data about individual patients nor does it contain any patient identifiable data. Using and interpreting the data Data from the National Lung Cancer Audit requires careful interpretation, and the information should not be looked at in isolation when assessing standards of care. Data are analysed either by cancer network or by place first seen in secondary care for the calendar year 2011. As a result, some trusts that only provide some specialist treatments for patients and do not routinely supply diagnostic data are not properly represented in these data. This is because all the analyses of the NLCA to date have been carried out by 'place first seen' and cancer networks. The ‘place first seen' most closely represents the Clinical Multi-Disciplinary Team (MDT) which makes the first treatment decisions (in partnership with representatives from the specialist centres who sit on these peripheral MDTs). We largely know the population base for these MDTs and that number provides the ‘denominator' for the outcome measures. It is much more difficult to define a population denominator for specialist centres and the treatment they provide is usually only one part of a complex care pathway. So taking the raw data at face value gives a very distorted picture both of their activity and performance. Accessing the data The data are being made available on the data.gov website. Each year two files of data from the National Lung Cancer Audit will be made available in CSV format. Trusts and Networks are identified by name and their national code. What does the data cover? The data measure levels of completeness for data submitted to the NLCA and measures of performance in the audit at trust level for key performance measures for assessing standards of care for lung cancer in secondary care. Details of these standards can be found in appendix 2 of the NLCA report. Are all Trusts included? All Trusts in England that manage patients diagnosed with lung cancer or mesothelioma are included. What period does the data cover? This data were extracted from the NLCA database in July 2012 and covers patients first seen in the calendar year 2011.

Summary

Description

Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister restated the commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. The National Lung Cancer Audit (NLCA) was identified as the pilot for this data release. These data will be released in an open and standardised format for the first time in December 2011, and provided annually from then onwards. Covering all Cancer Networks and NHS Trusts in England, the data from the audit includes information about data completeness, audit process and outcome measures. The data will be available in a pdf format in the National Lung Cancer Audit 2011 annual report. What information is being made available? Measures about the process of care given to patients Information about care outcomes and treatment. The data also provides Audit participation by Trust and data completeness for the key fields; These data do not list data about individual patients nor does it contain any patient identifiable data. Using and interpreting the data Data from the National Lung Cancer Audit requires careful interpretation, and the information should not be looked at in isolation when assessing standards of care. Data are provided either by cancer network or by place first seen in secondary care for the calendar year 2010. As a result, some trusts that only provide some specialist treatments for patients and do not supply diagnostic data are not properly represented in these data. This is because all the analyses of the NLCA to date have been carried out by 'place first seen' and cancer networks. The ‘place first seen' is the Clinical Multi-Disciplinary Team (MDT) which makes the first treatment decisions (in partnership with representatives from the specialist centres who sit on these peripheral MDTs). We largely know the population base for these MDTs and that number provides the ‘denominator' for the outcome measures. It is much more difficult to define a population denominator for specialist centres and the treatment they provide is usually only one part of a complex care pathway. So taking the raw data at face value gives a very distorted picture both of their activity and performance. Therefore their performance should not be assessed from the results as published here. These trusts do however fully participate in the audit by providing treatment data for the referring MDTs. The trusts concerned are: The Christie NHS Foundation Trust University Hospitals of South Manchester NHS Foundation Trust Clatterbridge Centre for Oncology NHS Foundation Trust Royal Brompton and Harefield NHS Foundation Trust The Royal Marsden NHS Foundation Trust Papworth Hospital NHS Foundation Trust Accessing the data The data are being made available on the data.gov website. Each year two files of data from the National Lung Cancer Audit will be made available in CSV format. Trusts and Networks are identified by name and their national code. What does the data cover? The data measure levels of completeness for data submitted to the NLCA and measures of performance in the audit at trust level for key performance measures for assessing standards of care for lung cancer in secondary care. Details of these standards can be found in appendix 2 of the NLCA report. Are all Trusts included? All Trusts in England that manage patients diagnosed with lung cancer or mesothelioma are included. What period does the data cover? This data were extracted from the NLCA database in July 2011 and covers patients first seen in the calendar year 2010.

Summary

Description

This document contains data from the National Neoantal Audit Programme Annual Report 2011. The audit aims to assess whether babies admitted to neonatal units receive consistent high quality care across England in relation to the audit questions, and identify areas for improvement in relation to delivery and outcomes of care. The cohort covered is babies discharged from a neonatal unit during the calendar year 2011. These data do not contain data about individual patients not do they contain any patient identifiable data.

Summary

Description

Development of the National Register for Social Housing (NROSH) was started by the Department for Communities and Local Government (DCLG) in 2004. NROSH aimed to be a database of all social housing properties in England, with a range of details captured on each property. NROSH was transferred to the Tenant Services Authority, the social housing regulator, in April 2010 and was discontinued in May 2011. Ownership of the latest NROSH dataset passed from the TSA to the Homes and Communities Agency (HCA) when responsibility for social housing regulation passed to the Regulation Committee of the HCA in April 2012. In addition to being out of date, the records submitted by social landlords to NROSH are of varying quantity and quality with many incomplete, inaccurate or missing records. The database may also contain a number of duplicate entries. Two datasets are available. One is the latest NROSH database held by the HCA as at May 2011. This release contains a large subset of the full NROSH dataset (48 from 201 fields in total; for 4,826,417 unique property records). The data in this release does not include those fields where data could enable specific identification of vulnerable people or other sensitive personal data. It also excludes fields where a minimum completion threshold is not met (generally fields where less than 25% of records have data). There are still issues of quality, incomplete data, and potential duplication of records in the data that accompanies this release that HCA is not able to resolve. Additional information, including data that falls below the minimum quality thresholds for this release, may be requested from the HCA (Referrals & Regulatory Enquiries Team, mail@homesandcommunities.co.uk). The 48 fields included in this release are summarised and described in the two tables accompanying this metadata. The data is contained in five compressed single CSV files: NROSH Data Extract Part 1; - 2; - 3; -4 and -5. Due to the large volume of records, analysis will require database software (MS Excel will not support analysis). Also available is a snapshot of the NROSH database held by DCLG as at March 2010. The data is that which was reported by social landlords in line with the system specifications and includes a selected set of fields on property address, type of accommodation, form of structure, number of rooms and bedspaces are included.

Summary

Description

Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. Each year data from the National Oesophago-gastric Cancer Audit will be made available in CSV format. The data are also being made available on the data.gov website. What information is being made available? Audit participation by NHS Trust and data completeness for the key fields. Measures about the process of care given to patients. Information about care outcomes and treatment. Trusts and Networks are identified by name and their national code. These data do not list individual patient information, nor do they contain any patient identifiable data. The National Oesophago-Gastric Cancer Audit covers the quality of care given to patients with Oesophago-Gastric (OG) cancer. The audit evaluates the process of care and the outcomes of treatment for all OG cancer patients, both curative and palliative. From April 2012, the audit has been extended to include patients with Oesophageal High-Grade Glandular Dysplasia (HGD). The National Oesophago-gastric Cancer Audit is a high profile, collaborative, national clinical audit for oesophago-gastric cancer run jointly by The Health and Social Care Information Centre, The Association of Upper Gastrointestinal Surgeons of Great Britain & Ireland (AUGIS), British Society of Gastroenterologists (BSG) and The Clinical Effectiveness Unit at the Royal College of Surgeons of England. The audit aims to improve the quality of care and survival of patients with Oesophago-gastric cancer. It meets the requirements as set out in the NHS Cancer Plan and NICE guidelines. The National Oesophago-gastric Cancer Audit 2010/11 covers the time period from 1st April 2010 to 31st March 2011 and only Hospital sites within England are included.